Reacting to the United States Food and Drug Administration (FDA) rejection of Bharat Biotech Covaxin jab for emergency use authorization, the Union Health M
New Delhi [India], June 11 (ANI): Reacting to the United States Food and Drug Administration (FDA)'s rejection of Bharat Biotech's Covaxin jab for emergency use authorization, the Union Health Ministry on Friday said that it respects the decision taken by the authority but it will not have any impact on India's vaccine plan.
Drug Controller General of India is satisfied with Covaxin data and so there will be no disruption in the vaccination programme going on in India owing to FDA's decision.